Using Activated Specie Patents (Class 436/35)
  • Patent number: 10427044
    Abstract: A game machine includes an operation acceptor, an output controller, and an evaluator. The operation acceptor is configured to accept an operation. The output controller is configured to display a reference indicator and a movement object, which moves toward the reference indicator, over the display screen. The output controller is configured to change a display position of the reference indicator and a movement direction of the movement object, based on a change condition. The evaluator is configured to evaluate the operation based at least in part on a first timing that the movement object reaches the reference indicator and a second timing that the operation acceptor accepts the operation.
    Type: Grant
    Filed: September 22, 2017
    Date of Patent: October 1, 2019
    Assignee: KONAMI DIGITAL ENTERTAINMENT CO., LTD.
    Inventor: Tahei Katagai
  • Patent number: 8986936
    Abstract: The present invention relates to methods and kits for the prediction of risk for heart failure using post-translation modified forms of cardiac troponin T as a biomarker.
    Type: Grant
    Filed: May 20, 2010
    Date of Patent: March 24, 2015
    Assignees: Inserm (Institut National de la Santa et de la Recherche Medicale), Institute Pasteur de Lille, Le Centre Hospitalier Regional Universitaire de Lille, Universite de Rouen
    Inventors: Florence Pinet, Paul Mulder, Christophe Bauters, Vincent Richard
  • Patent number: 8728822
    Abstract: Disclosed is a performance game, and more particularly is a method, an apparatus, and a recording medium for a performance game, which can provide various presentation effects with a simple presentation operation of a user.
    Type: Grant
    Filed: May 27, 2011
    Date of Patent: May 20, 2014
    Assignee: Neowiz Games Co., Ltd.
    Inventor: Hwi-Man Ryu
  • Patent number: 8673554
    Abstract: Disclosed are methods useful in multiplex cell-based assays for compound screening employing imaging instrumentation. The methods described herein offer high content information relating to the biological potency of test agents, off-target effects and cellular toxicity of potential drug candidates.
    Type: Grant
    Filed: January 15, 2009
    Date of Patent: March 18, 2014
    Assignee: Ge Healthcare UK Limited
    Inventor: Jeffrey K. Horton
  • Patent number: 8609432
    Abstract: Disclosed is a rapid, non-invasive and highly specific and sensitive diagnostic assay for the identification of individuals with autoimmune chronic urticaria, which makes use of CD203c, and in some embodiments, additional proteins, as a marker for the disease. Test kits for diagnosis of an individual suspected of having autoimmune chronic urticaria are also disclosed. Also disclosed are a method of identifying compounds useful for treating autoimmune chronic urticaria and a method of treating autoimmune chronic urticaria.
    Type: Grant
    Filed: August 7, 2012
    Date of Patent: December 17, 2013
    Inventors: Ronald Joseph Harbeck, Karen Mary Andrews, Donald MacGlashan
  • Patent number: 8546092
    Abstract: An embodiment relates to a method of detecting a drug resistance in a patient comprising adding nanoparticles to sample platelets to form activated platelets containing the nanoparticles and comparing a difference in activation of the activated platelets and the sample platelets. Another embodiment relates to a method of monitoring a thrombotic risk factor in a subject in a general population comprising adding nanoparticles to sample platelets to form activated platelets containing the nanoparticles and comparing a difference in activation of the activated platelets and the sample platelets. Yet another embodiment relates to a kit comprising nanoparticles, a fluorescence dye tagged antibody and optionally a buffer, wherein the kit is configured to detect a drug resistance in a patient or a likelihood of the thrombotic risk factor in a subject in general population.
    Type: Grant
    Filed: December 7, 2009
    Date of Patent: October 1, 2013
    Assignee: University of Calcutta
    Inventors: Suryyani Deb, Anjan Dasgupta, Prabir Lahiri
  • Patent number: 8409505
    Abstract: A sensor-dispensing instrument adapted to handle a sensor pack contains sensors and performs a test using one of the sensors. The instrument includes an outer housing and a mechanical mechanism for rotating the sensor pack and ejecting one of the sensors from the sensor pack and through a sensor slot on the housing. The instrument also includes a sensor actuator to engage with a sensor disposed in the sensor slot, and a sensor release that is movable to disengage the sensor actuator from the sensor disposed in the sensor slot and permit the discharge of the sensor. The sensor release activates a sensor release mechanism that has a sensor release aid arm, a mounting block, and a pivot pin. The sensor release aid arm contacts the sensor disposed in the sensor slot to assist removal of the sensor from the sensor slot.
    Type: Grant
    Filed: December 16, 2011
    Date of Patent: April 2, 2013
    Assignee: Bayer HealthCare LLC
    Inventors: Bruce A. Flora, John P. Creaven, Russell J. Micinski
  • Patent number: 8388435
    Abstract: A method of playing a wagering game comprises receiving a wager, and generating a randomly selected first outcome of a first wagering game, the first outcome comprising a first plurality of symbols arranged in a first matrix. The method further comprises generating a randomly selected second outcome of a second wagering game, the second outcome comprising a second plurality of symbols arranged in a second matrix, and simultaneously displaying the first outcome and the second outcome on at least one display. The method further comprises detecting an occurrence of a triggering event, in response to the triggering event, copying a first special symbol occurring in the first outcome into the second outcome to yield a modified second outcome, and evaluating the first outcome and the modified second outcome for winning combinations of symbols.
    Type: Grant
    Filed: May 28, 2009
    Date of Patent: March 5, 2013
    Assignee: WMS Gaming Inc.
    Inventors: Peter R. Anderson, Allon G. Englman, Benjamin T. Gomez, Joel R. Jaffe, Daniel P. Louie
  • Patent number: 8304521
    Abstract: Pax3, a member of the paired class homeodomain family of transcription factors and an essential protein for early skeletal muscle development, was shown to be phosphorylated in proliferating mouse primary myoblasts. Furthermore, Ser205, Ser201 and Ser209 were identified as the only sites of phosphorylation on Pax3 in proliferating mouse primary myoblasts. Phosphorylation of Ser205 was shown to be required for the efficient phosphorylation of Ser201 and/or Ser209. Site-specific antibodies were made to each of these three sites when phosphorylated. These three sites are also present and phosphorylated in the Pax3-FOXO1 fusion protein, and phosphorylation of these sites may play a role in ARMS. Thus, these new antibodies may be used in studying the regulation of nerve and muscle development and differentiation and in finding therapeutic solutions for certain disorders, including Waardenburg syndrome and childhood solid muscle tumor alveolar rhabdomyosarcoma (ARMS).
    Type: Grant
    Filed: June 3, 2009
    Date of Patent: November 6, 2012
    Assignee: Board of Supervisors of Louisiana State University And Agricultural and Mechanical College
    Inventors: Andrew D. Hollenbach, Patrick J. Miller, Kevin N. Dietz
  • Patent number: 8288119
    Abstract: Human PGD genes are identified as modulators of the PTEN pathway, and thus are therapeutic targets for disorders associated with defective PTEN function. Methods for identifying modulators of PTEN, comprising screening for agents that modulate the activity of PGD are provided.
    Type: Grant
    Filed: June 20, 2005
    Date of Patent: October 16, 2012
    Assignee: Exelixis, Inc.
    Inventors: Chunyan Song, Michael Martin Ollmann, Lynn Margaret Bjerke
  • Patent number: 8263355
    Abstract: Disclosed is a rapid, non-invasive and highly specific and sensitive diagnostic assay for the identification of individuals with autoimmune chronic urticaria, which makes use of CD203c, and in some embodiments, additional proteins, as a marker for the disease. Test kits for diagnosis of an individual suspected of having autoimmune chronic urticaria are also disclosed. Also disclosed are a method of identifying compounds useful for treating autoimmune chronic urticaria and a method of treating autoimmune chronic urticaria.
    Type: Grant
    Filed: June 29, 2010
    Date of Patent: September 11, 2012
    Inventors: Ronald Joseph Harbeck, Karen Mary Andrews, Donald MacGlashan, Jr.
  • Publication number: 20120052481
    Abstract: Provided are methods and compositions which are useful for separating, isolating, detecting, and quantifying compounds of interest which have been modified chemically, enzymatically or catalytically from other compounds which have not been so modified. The modifications may take the form of functional groups which are gained, lost or retained by the compounds of interest.
    Type: Application
    Filed: August 24, 2010
    Publication date: March 1, 2012
    Applicant: ENZO LIFE SCIENCES, INC., C/O ENZO BIOCHEM, INC.
    Inventors: Elazar Rabbani, Joshua Rabbani, Praveen Pande, Jannis G. Stavrianopoulos
  • Patent number: 8101126
    Abstract: A sensor-dispensing instrument (10) adapted to handle a sensor pack containing a plurality of sensors and to perform a test using one of the sensors. The sensor-dispensing instrument includes an outer housing (12) and a mechanical mechanism contained therein for rotating the sensor pack and ejecting one of the sensors from the sensor pack and through a sensor slot on the housing. The sensor-dispensing instrument also includes a sensor actuator to engage with a sensor disposed in the sensor slot, and a sensor release (66) that is movable to disengage the sensor actuator from the sensor disposed in the sensor slot and permit the discharge of the sensor the sensor release additionally activating a sensor release mechanism that has a sensor release aid arm, a mounting block, and a pivot pin that connects the sensor release aid arm to the mounting block, wherein the sensor release aid arm is adapted to contact the sensor disposed in the sensor slot to assist removal of the sensor from the sensor slot.
    Type: Grant
    Filed: April 25, 2006
    Date of Patent: January 24, 2012
    Assignee: Bayer HealthCare LLC
    Inventors: Bruce A. Flora, John P. Creaven, Russell J. Micinski
  • Patent number: 7981365
    Abstract: A device having an air sampler, an electrospray apparatus, and a fluorescence excitation and detection system. The air sampler is capable of moving air suspected of containing a biological or chemical aerosol particle into a chamber. The electrospray apparatus is capable of spraying a charged solution into the chamber to coat the aerosol particles with a coating. The solution has a fluorescent-labeled biological or chemical marker capable of specific binding to the aerosol particle. The fluorescence system is capable of detecting fluorescence of the fluorescent label in the coating. A method of detecting the aerosol particle by: moving air suspected of containing the aerosol particle into a chamber; spraying the charged solution into the chamber with an electrospray apparatus, such that a coating of the solution is formed around the particle; exciting the fluorescent label; and detecting fluorescence of the fluorescent label.
    Type: Grant
    Filed: September 15, 2005
    Date of Patent: July 19, 2011
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: Matthew Hart, Horn Bond Lin, Jay Eversole
  • Patent number: 7977063
    Abstract: The present invention concerns a method for determining an allergic response by determining the extent of degranulation of human IgE sensitized cells upon activation by allergens in food products.
    Type: Grant
    Filed: March 16, 2005
    Date of Patent: July 12, 2011
    Assignee: N.V. Nutricia
    Inventors: Virginie Sophie Christelle Tregoat, Johan Garssen
  • Publication number: 20110129930
    Abstract: In an embodiment, there is disclosed an inspection method for detecting the presence of imprintable medium on an imprint lithography template. The method includes contacting the imprint lithography template with a marker, the marker being attachable to imprintable medium that may be on the imprint lithography template, the marker being configured to interact with incident radiation when attached to the imprintable medium, directing radiation at the imprint lithography template, and measuring radiation re-directed by the imprint lithography template to attempt to detect presence of a marker that has attached to the imprintable medium, from the interaction of the marker with the incident radiation, and thus detect the presence of imprintable medium to which the marker is attached.
    Type: Application
    Filed: November 29, 2010
    Publication date: June 2, 2011
    Applicant: ASML Netherlands B.V.
    Inventor: Sander Frederik WUISTER
  • Patent number: 7863047
    Abstract: New intracorporeal photodynamic medicaments and certain medical uses and methods for use of such photodynamic medicaments for treatment of disease in human or animal tissue are described, wherein a primary active component of such medicaments is a halogenated xanthene or halogenated xanthene derivative. In preferred embodiments, such medicaments are used for treatment of a variety of conditions affecting the skin and related organs, the mouth and digestive tract and related organs, the urinary and reproductive tracts and related organs, the respiratory tract and related organs, the circulatory system and related organs, the head and neck, the endocrine and lymphoreticular systems and related organs, various other tissues, such as connective tissues and various tissue surfaces exposed during surgery, as well as various tissues exhibiting microbial or parasitic infection.
    Type: Grant
    Filed: April 25, 2008
    Date of Patent: January 4, 2011
    Assignee: Provectus Pharmatech, Inc.
    Inventors: H. Craig Dees, Timothy C. Scott, Eric A. Wachter, Walter G. Fisher, John Smolik
  • Patent number: 7772011
    Abstract: Disclosed is a rapid, non-invasive and highly specific and sensitive diagnostic assay for the identification of individuals with autoimmune chronic urticaria, which makes use of CD203c, and in some embodiments, additional proteins, as a marker for the disease. Test kits for diagnosis of an individual suspected of having autoimmune chronic urticaria are also disclosed. Also disclosed are a method of identifying compounds useful for treating autoimmune chronic urticaria and a method of treating autoimmune chronic urticaria.
    Type: Grant
    Filed: March 21, 2006
    Date of Patent: August 10, 2010
    Inventors: Ronald Joseph Harbeck, Karen Mary Andrews, Donald MacGlashan, Jr.
  • Patent number: 7695924
    Abstract: The invention provides methods and compositions for simultaneously detecting the activation state of a plurality of proteins in single cells using flow cytometry. The invention further provides methods and compositions of screening for bioactive agents capable of coordinately modulating the activity of a plurality of proteins in single cells. The methods and compositions can be used to determine the protein activation profile of a cell for predicting or diagnosing a disease state, and for monitoring treatment of a disease state.
    Type: Grant
    Filed: January 18, 2007
    Date of Patent: April 13, 2010
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Omar D. Perez, Garry P. Nolan
  • Patent number: 7563584
    Abstract: The invention provides methods and compositions for simultaneously detecting the activation state of a plurality of proteins in single cells using flow cytometry. The invention further provides methods and compositions of screening for bioactive agents capable of coordinately modulating the activity of a plurality of proteins in single cells. The methods and compositions can be used to determine the protein activation profile of a cell for predicting or diagnosing a disease state, and for monitoring treatment of a disease state.
    Type: Grant
    Filed: July 10, 2002
    Date of Patent: July 21, 2009
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Omar D. Perez, Garry P. Nolan
  • Publication number: 20090068747
    Abstract: Subject of the present invention is to provide an apparatus, an instrument, and a method particularly useful in multiplex PCR applications permitting short sample measuring times of many samples combined with high sensitivity.
    Type: Application
    Filed: February 19, 2008
    Publication date: March 12, 2009
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventor: Roger Iten
  • Patent number: 7402299
    Abstract: New intracorporeal photodynamic medicaments and certain medical uses and methods for use of such photodynamic medicaments for treatment of disease in human or animal tissue are described, wherein a primary active component of such medicaments is a halogenated xanthene or halogenated xanthene derivative. In preferred embodiments, such medicaments are used for treatment of a variety of conditions affecting the skin and related organs, the mouth and digestive tract and related organs, the urinary and reproductive tracts and related organs, the respiratory tract and related organs, the circulatory system and related organs, the head and neck, the endocrine and lymphoreticular systems and related organs, various other tissues, such as connective tissues and various tissue surfaces exposed during surgery, as well as various tissues exhibiting microbial or parasitic infection.
    Type: Grant
    Filed: November 30, 2004
    Date of Patent: July 22, 2008
    Assignee: Provectus Pharmatech, Inc.
    Inventors: H. Craig Dees, Timothy C. Scott, Eric A. Wachter, Walter G. Fisher, John Smolik
  • Patent number: 7384623
    Abstract: High energy phototherapeutic agents or radiosensitizer agents comprised of a halogenated xanthene, or other related agents that exhibit a preference for concentration in biologically sensitive structures in diseased tissue, and methods of treating and imaging using such radiosensitizer agents in such diseased tissue are described herein.
    Type: Grant
    Filed: August 25, 1999
    Date of Patent: June 10, 2008
    Assignee: Provectus Pharmatech, Inc.
    Inventors: H. Craig Dees, Timothy Scott, John T. Smolik, Eric A. Wachter
  • Patent number: 7201879
    Abstract: An aerosol-into-liquid collector (ALC) for collecting gas-borne particles from a large volume of gas such as air into a small volume of liquid is described. The ALC uses a linear quadrupole to concentrate particles flowing in a gas and to help direct these concentrated particles toward a small volume of collection liquid so that these particles tend to combine with a small volume of collection liquid that can then be drawn from the ACL for further analysis. The particles in the gas are typically given a charge that is opposite to that of the charge imparted to the volume of collection liquid so that electrostatic forces help draw particles from the flowing gas into the small volume of liquid. The linear quadrupole focuses toward it axis particles that have the charge, mass and mobility to be stable in the linear quadrupole.
    Type: Grant
    Filed: November 19, 2004
    Date of Patent: April 10, 2007
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Steven Clyde Hill, Horn-Bond Lin
  • Patent number: 7201878
    Abstract: Aerosol particle analyzer (APA) for measuring an analyte in airborne particle is described. Airborne particles are first given an electrical charge and then drawn in air past an oppositely charged volume of an analysis liquid that exposed to the air at a small hole in a container, such as a capillary, that holds that analysis liquid. Electrostatic forces enhance the rate that the airborne particles collide with the small exposed volume of the analysis liquid in the hole. If the particles that collide with the analysis liquid contain the analyte, an optical property of the analysis liquid, such as the fluorescence, varies according to the amount of the analyte in the particles. This optical property is measured and the amount of analyte in the particles is determined from the measured optical property.
    Type: Grant
    Filed: March 26, 2004
    Date of Patent: April 10, 2007
    Assignee: The United States of America as Represented by the Secretary of the Army
    Inventors: Horn-Bond Lin, Steven Clyde Hill
  • Patent number: 7193705
    Abstract: A method for determining atomic isotope masses in mass spectrometry, atomic isotope ratios being determined from molecular isotope ratios measured by means of an isotope mass spectrometer—ion correction, the determination of the atomic ratios being carried out by setting up and solving a system of equations which describes relationships between the atomic and the molecular ratios, and the system of equations having to have at least as many independent equations as there are atomic ratios. The entire system of equations is linearized by means of suitable numerical methods in a first step, in particular by means of a Taylor expansion or similar method, and in which the linearized system of equations is subsequently solved as a whole without transforming the individual equations.
    Type: Grant
    Filed: September 8, 2004
    Date of Patent: March 20, 2007
    Assignee: Thermo Electron (Bremen) GmbH
    Inventor: Hans-Jürgen Schlüter
  • Patent number: 7153475
    Abstract: Aerosol particle analyzer (APA) for measuring the amount of analyte in airborne particle is described. The APA uses an analysis liquid. In most embodiments, this analysis liquid is chosen so that when it is mixed with the particles, an optical property of the analysis liquid (AL) varies according to the amount of the analyte in the particles. Airborne particles are drawn into the instrument, and detected using optical methods such as light scattering or laser-induced fluorescence. When a particle of interest is detected, a charged droplet of the analysis liquid (CDAL) is ejected so that it collides with the detected particle and moves into a horizontally oriented linear quadrupole that is in an airtight container, except for small orifices to let the CDAL enter and exit.
    Type: Grant
    Filed: May 9, 2005
    Date of Patent: December 26, 2006
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Steven Clyde Hill, Richard Kounai Chang, Jean-Pierre Wolf
  • Patent number: 7125518
    Abstract: Aerosol particle analyzer (APA) for measuring the amount of analyte in airborne particle is described. The APA uses an analysis liquid. When this analysis liquid is mixed with the particles, an optical property of the analysis liquid (CDAL) varies according to the amount of the analyte in the particles. A charged droplet of the analysis liquid is levitated. Airborne particles are drawn into the instrument and given a charge that is opposite that of the CDAL, and made to flow near the CDAL so that electrostatic forces greatly increase the probability that the CDAL and charged particles will combine. Then the CDAL is ejected into a horizontally oriented linear quadrupole that is in an airtight container, except for a small orifice to let the CDAL enter. The CDAL is levitated in a high humidity environment so that it evaporates slowly, so that there is time for the reaction between the analyte, if any, and the CDAL can take place, and so that the optical property, typically fluorescence, can be measured.
    Type: Grant
    Filed: February 14, 2004
    Date of Patent: October 24, 2006
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventor: Steven Clyde Hill
  • Patent number: 7112450
    Abstract: The present invention relates to conducting a plurality of chemical reactions in a system including an apparatus which provides energy for the chemical reactions, such as chemical reactions in organic synthesis, where a particular advantage is the use of predetermined reaction parameters corresponding to similar chemical reactions. The present invention also relates to a system for performing said method and to corresponding kits and software. The system comprises an apparatus which can provide energy for the chemical reactions, said apparatus comprising a reaction cavity and a liquid handler, and a parameter selecting unit having a user interface means, a search unit means, apparatus control unit means, and storage means for carrying a database.
    Type: Grant
    Filed: May 7, 2001
    Date of Patent: September 26, 2006
    Assignee: Personal Chemistry I Uppsala AB
    Inventors: Magnus Fagrell, Jacob Westman
  • Patent number: 7060447
    Abstract: Intracellular translocation of proteins, particularly protein kinase C (PKC) isoenzymes, provides a surrogate test system for determining toxicity of candidate compounds. The profile of translocation with respect to at least one and preferably two or more signal transduction proteins can be correlated with-that of known toxins. In addition, databases of such profiles with respect to toxins of various types provide a useful set of standards for evaluating toxicity of candidate compounds. Moreover, to the extent that a toxin's profile mimics that found in a diseased state, the toxin can be used to construct screens for compounds alleviating the disease.
    Type: Grant
    Filed: November 13, 2003
    Date of Patent: June 13, 2006
    Assignee: Trellis Bioscience, Inc.
    Inventor: Lawrence M. Kauvar
  • Patent number: 6673554
    Abstract: Intracellular translocation of proteins, particularly protein kinase C (PKC) isoenzymes, provides a surrogate test system for determining toxicity of candidate compounds. The profile of translocation with respect to at least one and preferably two or more signal transduction proteins can be correlated with that of known toxins. In addition, databases of such profiles with respect to toxins of various types provide a useful set of standards for evaluating toxicity of candidate compounds. Moreover, to the extent that a toxin's profile mimics that found in a diseased state, the toxin can be used to construct screens for compounds alleviating the disease.
    Type: Grant
    Filed: June 14, 1999
    Date of Patent: January 6, 2004
    Assignee: Trellie Bioinformatics, Inc.
    Inventor: Lawrence M. Kauvar
  • Patent number: 6531320
    Abstract: A method of judging the redox (oxidation-reduction) in human blood plasma precisely in a short time using electron spin resonance (ESR) spectroscopy is provided. Also, a method of evaluating the functions of human kidneys, judging whether a dialysis is necessary, determining the dialysis time and judging the usefulness of dialysis materials is offered. First, a spin-trapping agent such as PBN is added to a human blood plasma, resulting in hydroxyl radicals in the plasma. The radicals are trapped and converted into a stable spin adduct (PBN-OH). The amount of the spin adduct is measured by an ESR spectrometer.
    Type: Grant
    Filed: February 3, 1999
    Date of Patent: March 11, 2003
    Inventors: Masahiro Kohno, Shigeru Ohwada
  • Patent number: 6100093
    Abstract: The invention relates to a method for determining the quality of a crop, comprising the determination of at least one characteristic parameter of the photosynthesis process of the crop, which parameter serves as a quality indicator for the crop, wherein the parameter belongs to the photosystem I (PSI), which is known per se, and wherein the determination of the parameter comprises the following steps: (a) bringing at least some of a number of types of molecules which are located on the donor side of PSI into an oxidised state; (b) allowing at least some of the oxidised molecules to be reduced; and (c) determining a relaxation parameter which contains information on the rate of the reduction, wherein step (c) comprises at least the following sub-steps: (1) measurement of absorption of light in a predetermined wavelength region by the oxidised molecules in the crop during the reduction, and (2) calculation of a rate parameter which contains information on the rate of a change in the measured absorption as a fun
    Type: Grant
    Filed: October 9, 1998
    Date of Patent: August 8, 2000
    Assignee: Instituut Voor Agrotechnologisch Onderzoek (ATO-DLO)
    Inventors: Olaf Van Kooten, Jeremy Harbinson
  • Patent number: 5892364
    Abstract: A method and apparatus for the detection of trace constituents in inert gases. Three modes of operation of the said invention are most preferred. In the first embodiment, a dielectric barrier discharge cell receives an inert gas, excites the gas, and the gas is then allowed to mix with additional gas in which the constituent to be measured is entrained. Energy is then passed from the excited states of the inert gas to the analytes of interest creating charged analytes of interest which are then measured through the use of commercial electrometers. In a second embodiment, the dielectric barrier discharge device receives the analyte entrained within the inert gas and the gas and, in some cases, the analytes are excited. The excited species then pass on and any resulting ionized species are then detected through the use of an electrometer.
    Type: Grant
    Filed: September 11, 1997
    Date of Patent: April 6, 1999
    Inventor: Matthew Monagle
  • Patent number: 5783445
    Abstract: The isotopic composition of a multiatomic isotope-bearing species such as CO.sub.2 in an analyte is measured by maintaining the analyte in a condition such that isotope-bearing species are present in an excited state and directing light at wavelengths corresponding to transition energies of isotope-bearing species with different isotopes. The interaction between the analyte and light at the different wavelengths is monitored, as by monitoring the optogalvanic effect caused by the light of the different wavelengths. The light may be supplied by a laser including the isotope-bearing species. A stable isotope such as .sup.13 C or .sup.18 O can be used as a tracer in a chemical or biological test and detected using the composition-determining method.
    Type: Grant
    Filed: October 3, 1994
    Date of Patent: July 21, 1998
    Assignee: Rutgers, The State University
    Inventor: Daniel E. Murnick
  • Patent number: 5618682
    Abstract: The present invention provides a method of increasing the duration of detectable photon emission of a luciferase-luciferin reaction. The method provides a luciferase-luciferin reaction in which photon emission can be detected for up to and including eight hours. A method of the present invention can also be used to detect the presence of luciferase in biological samples. The present invention also provides a composition used in detecting the presence of luciferase in biological samples.
    Type: Grant
    Filed: February 8, 1994
    Date of Patent: April 8, 1997
    Assignee: Packard Instrument Co., Inc.
    Inventor: Winfried Scheirer
  • Patent number: 5441890
    Abstract: A method of destabilizing the homogeneous steady state of a dynamical system with two or more dynamically coupled variables through the action of a differential bulk flow of the key species, termed Differential Flow Induced Instability (DIFII), is disclosed. The DIFII is also applicable to systems with time periodic (limit cycle) and aperiodic (chaotic) states. Turing predicted that in systems characterized by activator/inhibitor kinetics a homogeneous, stable steady state of the reactive system may lose its stability and form inhomogeneous patterns due to the interaction of diffusion and reaction when the diffusion coefficient of the inhibitor is sufficiently greater than that of the activator. This mechanism is believed to form the basis of biological morphogenesis.
    Type: Grant
    Filed: May 28, 1993
    Date of Patent: August 15, 1995
    Assignees: Michael Menzinger, Arkady B. Rovinsky
    Inventors: Michael Menzinger, Arkady Rovinsky
  • Patent number: 5332677
    Abstract: A new method of inducing spatiotemporal structures in systems characterized by activation/inhibition kinetics through the action of a differential bulk flow of the key species is disclosed. As Turing predicted, a homogeneous and otherwise stable steady state of a reactive system may lose its stability and form inhomogeneous patterns due to the interaction of diffusion and reaction. This mechanism is believed to form the basis of biological morphogenesis. The Turing instability only arises in systems wherein the diffusion coefficient of the inhibitor is sufficiently greater than that of the activator. The method of the present invention avoids this constraint by using a differential flow between the activation and the inhibition species rather than a differential diffusivity. In one aspect of the invention, this differential flow is achieved by immobilizing one of either the inhibitor or activator species in the flow system containing the other species.
    Type: Grant
    Filed: August 20, 1992
    Date of Patent: July 26, 1994
    Inventors: Michael Menzinger, Arkady Rovinsky
  • Patent number: 5242805
    Abstract: The claimed invention relates to a substrate for evaluating glycosidic enzymes comprising a resorufin derivative of the general formula: ##STR1## wherein Gly is a carbohydrate bonded to resorufin by a glycosidic linkage; where at least one of substituents R.sub.1, R.sub.2, R.sub.4, R.sub.6, R.sub.8, and R.sub.9 is a lipophilic residue of the formula --L(CH.sub.2).sub.n CH.sub.3, where n is greater than 3 and less than 22, and where L is a methylene --CH.sub.2 --, an amide --NHCO--, a sulfonamide --NHSO.sub.2 --, a carboxamide --CONH--, a carboxylate ester --COO--, a urethane --NHCOO--, a urea --NHCONH--, or a thiourea --NHCSNH--; andwhere the remainder of substituents R.sub.1, R.sub.2, R.sub.4, R.sub.6, R.sub.8, and R.sub.9, which may be the same or different, are hydrogen, halogen, or other lipophilic residues, which may be the same or different, containing from about 1 to about 22 carbon atoms of the formula --L'(CH.sub.2).sub.m CH.sub.3, where m is less than 22, and where L' is a methylene --CH.sub.
    Type: Grant
    Filed: August 23, 1991
    Date of Patent: September 7, 1993
    Assignee: Molecular Probes, Inc.
    Inventors: John J. Naleway, Yu-zhong Zhang, Richard P. Haugland
  • Patent number: 5231006
    Abstract: A method for the determination of plasminogen in body fluids in the presence of streptokinase using a substrate for plasmin, the action of plasmin on which results in a cleavage product which can be measured optically, which method comprises essentially simultaneous addition of streptokinase and chromogenic or fluorogenic substrate for plasmin to the body fluid, and determination of the amount of the cleavage product formed in a defined time, or of the rate of formation of the cleavage product, and from this the concentration of plasminogen, is described. When the amount of streptokinase which is used is such that the plasminogen present is in molar excess, this method can be used to determine the rate of activation of plasminogen.
    Type: Grant
    Filed: September 14, 1990
    Date of Patent: July 27, 1993
    Assignee: Behringwerke Aktiengesellschaft
    Inventor: Hans-Jurgen Kolde
  • Patent number: 5198336
    Abstract: A bioassay making use of submitochondrial particles to test for the presence of toxic substances which induce prooxidant states in vivo. The assay uses complex I of the electron transport enzymes on the submitochondrial particles which are capable of donating electrons to the toxicant in solution. The presence of any activated oxygen species in the assay solution is detected spectrophotometrically by the adrenochrome reaction.
    Type: Grant
    Filed: May 8, 1989
    Date of Patent: March 30, 1993
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Lynda M. Knobeloch, George A. Blondin, John M. Harkin
  • Patent number: 4952513
    Abstract: The present invention provides a general assay methodology suitable for the detection of organic analytes which are neither aldehydes nor ketones and for inorganic substances. The methodology utilizes prepared sensitized films of derivatizing agents and specific developer solutions for the selective and controlled formation of light scattering crystals whose presence serves as a qualitative and/or quantitative measure of the individual analyte of interest in the sample.
    Type: Grant
    Filed: October 24, 1988
    Date of Patent: August 28, 1990
    Assignee: Crystal Diagnostics, Inc.
    Inventor: Martin Koocher
  • Patent number: 4828800
    Abstract: A system for the detection of trace components in a gas by a process involving the ionization of such trace components and intermittently adding to the gas, a reactant gas which converts some of the components to more readily ionizable forms.
    Type: Grant
    Filed: October 16, 1985
    Date of Patent: May 9, 1989
    Assignee: Brunswick Corporation
    Inventor: Bruce W. Castleman
  • Patent number: 4780284
    Abstract: Apparatus for detecting gas in a sample gas in a carrier gas stream and including a windowless ionization detector having a pulsed power supply which is switchable at a rate which provides a pulse period shorter that the transit time of ions to be detected to the collector electrode of an ionization chamber of the detector. Switching allows any signal due to ion detection to be separated from background noise due to other effects in the chamber.
    Type: Grant
    Filed: March 27, 1986
    Date of Patent: October 25, 1988
    Assignee: Hewlett-Packard Company
    Inventor: James E. Lovelock
  • Patent number: 4637938
    Abstract: The present invention generally relates to the use of fluorescence signals obtained by selective optical excitation to detect and monitor a species present during a flow reaction or decomposition of various reactants. These reactions were analyzed in situ using a tunable laser as a selective excitation source in combination with a reactor inducing such reactions with a diffusion flame or a plasma. The resultant spectra and analysis presented herein demonstrates the detection of new compositions like SiHF in the gas phase. The invention allows for pinpoint spatial probing of the reactor without perturbing the reaction. Thus, a deposition process can be controlled by monitoring a selected species and adjusting the deposition reaction parameters in response to the species' mere detection or relative concentration.
    Type: Grant
    Filed: August 19, 1983
    Date of Patent: January 20, 1987
    Assignee: Energy Conversion Devices, Inc.
    Inventors: Henry Lee, John P. deNeufville, Stanford R. Ovshinsky
  • Patent number: 4515896
    Abstract: A method for determining the spatial and phase distribution of a liquid-vapor multiphase fluid. The method comprises adding a fluorescent monomer and a quencher to the fluid to be studied. The fluid is then dispersed and the monomer excited. The excited monomer combines with the quencher to form a fluorescent exciplex. The monomer fluorescence is predominantly in the vapor phase and the exciplex fluorescence is predominantly in the liquid phase.
    Type: Grant
    Filed: December 12, 1983
    Date of Patent: May 7, 1985
    Assignee: United Technologies Corporation
    Inventor: Lynn A. Melton
  • Patent number: 4427633
    Abstract: For use in a system for analyzing sample constituents by metastable transfer emission spectroscopy, an improved apparatus for mixing a sample gas with a metastable gas. The apparatus provides an unobstructed path for the flow of sample gas so as to minimize deposition of the sample on walls of the apparatus. The apparatus may comprise an annular manifold coaxially mounted around a conduit through which flows the sample, or it may comprise a collar detachably connected in line with such a conduit.
    Type: Grant
    Filed: July 3, 1980
    Date of Patent: January 24, 1984
    Assignee: Beckman Instruments, Inc.
    Inventors: Jon R. Peacock, Robert L. Schmidt
  • Patent number: 4420255
    Abstract: A research type burner is provided which permits ready optical access for study of precombustion and primary reaction zones of adiabatic flames of premixed gases. The burner includes a channel for relatively laminar gas flow having an outlet with a pair of essentially parallel closely spaced knife edges for providing an essentially stable and adiabatic flame. The knife edges project sufficiently above the burner housing to allow the passage of a laser beam between the knife edges through the zone to be studied.
    Type: Grant
    Filed: September 16, 1981
    Date of Patent: December 13, 1983
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Mark A. DeWilde, Richard A. Beyer